BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17244467)

  • 1. [The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease].
    Chen SH; Li YM; Yu CH; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):64-5. PubMed ID: 17244467
    [No Abstract]   [Full Text] [Related]  

  • 2. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio.
    Chen S; Li Y; Li S; Yu C
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1415-8. PubMed ID: 18853997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
    Zheng L; Lv GC; Sheng J; Yang YD
    J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
    Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
    Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the genes encoding the peroxisome proliferator-activated receptors alpha and gamma in psoriasis.
    Mössner R; Kaiser R; Matern P; Krüger U; Westphal GA; Brockmöller J; Ziegler A; Neumann C; König IR; Reich K
    Arch Dermatol Res; 2004 Jun; 296(1):1-5. PubMed ID: 15083308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases].
    Peng X; Zhang L; Wang Q; Cui X
    Wei Sheng Yan Jiu; 2009 Jul; 38(4):401-4. PubMed ID: 19689066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
    Skrtic S; Carlsson L; Ljungberg A; Lindén D; Michalik L; Wahli W; Oscarsson J
    Liver Int; 2005 Feb; 25(1):33-40. PubMed ID: 15698396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha and its response element are required but not sufficient for transcriptional activation of the mouse heart-type fatty acid binding protein gene.
    Kawabe K; Saegusa H; Seto K; Urabe H; Motojima K
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1534-46. PubMed ID: 15833283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between PPARalpha gene polymorphisms and myocardial infarction.
    Reinhard W; Stark K; Sedlacek K; Fischer M; Baessler A; Neureuther K; Weber S; Kaess B; Wiedmann S; Mitsching S; Lieb W; Erdmann J; Meisinger C; Doering A; Tolle R; Jeron A; Riegger G; Hengstenberg C
    Clin Sci (Lond); 2008 Nov; 115(10):301-8. PubMed ID: 18336366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between tumor necrosis factor-alpha gene polymorphism and insulin resistance in nonalcoholic fatty liver disease].
    Huang J; Li YY; Zhou YJ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):613-5. PubMed ID: 16938178
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.
    Caron-Dorval D; Paquet P; Paradis AM; Rudkowska I; Lemieux S; Couture P; Vohl MC
    J Nutrigenet Nutrigenomics; 2008; 1(4):205-12. PubMed ID: 19776627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways.
    Dyrøy E; Yndestad A; Ueland T; Halvorsen B; Damås JK; Aukrust P; Berge RK
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1364-9. PubMed ID: 15920037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity.
    Rudkowska I; Caron-Dorval D; Verreault M; Couture P; Deshaies Y; Barbier O; Vohl MC
    Mol Nutr Food Res; 2010 Apr; 54(4):543-50. PubMed ID: 19937854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans.
    Jun DW; Han JH; Jang EC; Kim SH; Kim SH; Jo YJ; Park YS; Chae JD
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):667-72. PubMed ID: 19262398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Kuulasmaa T; Chiasson JL; Laakso M;
    Diabetes; 2007 Apr; 56(4):1181-6. PubMed ID: 17317762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.